Alvotech (NASDAQ:ALVOW – Get Free Report) saw a significant growth in short interest in the month of January. As of January 30th, there was short interest totaling 1,428 shares, a growth of 32.7% from the January 15th total of 1,076 shares. Based on an average daily volume of 4,077 shares, the days-to-cover ratio is currently 0.4 days. Based on an average daily volume of 4,077 shares, the days-to-cover ratio is currently 0.4 days.
Alvotech Price Performance
NASDAQ ALVOW opened at $0.30 on Tuesday. The company has a fifty day simple moving average of $0.60 and a 200 day simple moving average of $0.98. Alvotech has a 12-month low of $0.23 and a 12-month high of $3.00.
Alvotech Company Profile
Alvotech is a biopharmaceutical company specializing in the development and manufacturing of biosimilar medicines. Headquartered in Reykjavík, Iceland, the company focuses on creating high-quality, cost-effective alternatives to branded biologic therapies. Since its founding in 2013, Alvotech has built an integrated platform that spans research and development, clinical trials, regulatory submissions and commercial manufacturing.
Alvotech’s pipeline includes multiple biosimilar candidates addressing key therapeutic areas such as immunology, oncology and ophthalmology.
Featured Articles
- Five stocks we like better than Alvotech
- Your Bank Account Is No Longer Safe
- Nvidia CEO Issues Bold Tesla Call
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
Receive News & Ratings for Alvotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alvotech and related companies with MarketBeat.com's FREE daily email newsletter.
